Ms. Broadfoot currently serves as the Chief Financial Officer of aTyr Pharma, Inc., a position she has held since July 2018. From January 2017 to July 2018, she served as Chief Financial Officer of Emerald Health Pharmaceuticals Inc. and Emerald Health Bioceuticals Inc., where she was responsible for establishing operations for the US-based pharmaceutical and bioceutical entities, as well as the establishment of operations, corporate governance, finance and accounting, and investor relations functions, among other responsibilities.
Prior to Emerald Health, Ms. Broadfoot served as Vice President, US Corporate Controller, at GW Pharmaceuticals from May 2016 to January 2017. While at GW Pharmaceuticals, her responsibilities included establishing US commercial operations and implementing US public company financial and accounting standards in connection with the transfer of corporate operations from the UK to the US. Prior to joining GW Pharmaceuticals, Ms. Broadfoot served as Chief Financial Officer of Vical Inc. from October 2004 to March 2013, where she had oversight of finance, investor relations, manufacturing, information technology, human resources, and business development.
Ms. Broadfoot holds a Bachelor of Science degree in business administration and accounting from San Diego State University and is a certified public accountant.
What is Jill Marie Broadfoot's net worth?
The estimated net worth of Jill Marie Broadfoot is at least $26.29 thousand as of February 4th, 2025. Broadfoot owns 31,763 shares of aTyr Pharma stock worth more than $26,293 as of December 5th. This net worth approximation does not reflect any other investments that Broadfoot may own. Additionally, Broadfoot receives a salary of $544,750.00 as CFO at aTyr Pharma. Learn More about Jill Marie Broadfoot's net worth.
How old is Jill Marie Broadfoot?
Broadfoot is currently 62 years old. There are 3 older executives and no younger executives at aTyr Pharma. The oldest executive at aTyr Pharma is Dr. David J. King Ph.D., Scientific Consultant, who is 65 years old. Learn More on Jill Marie Broadfoot's age.
What is Jill Marie Broadfoot's salary?
As the CFO of aTyr Pharma, Inc., Broadfoot earns $544,750.00 per year. The highest earning executive at aTyr Pharma is Dr. Sanjay S. Shukla M.D., M.S., President, CEO & Director, who commands a salary of $768,180.00 per year. Learn More on Jill Marie Broadfoot's salary.
How do I contact Jill Marie Broadfoot?
Has Jill Marie Broadfoot been buying or selling shares of aTyr Pharma?
Jill Marie Broadfoot has not been actively trading shares of aTyr Pharma over the course of the past ninety days. Most recently, Jill Marie Broadfoot sold 1,254 shares of the business's stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $3.78, for a transaction totalling $4,740.12. Following the completion of the sale, the chief financial officer now directly owns 31,763 shares of the company's stock, valued at $120,064.14. Learn More on Jill Marie Broadfoot's trading history.
Who are aTyr Pharma's active insiders?
Are insiders buying or selling shares of aTyr Pharma?
In the last year, aTyr Pharma insiders bought shares 3 times. They purchased a total of 1,003,750 shares worth more than $927,719.96. In the last year, insiders at the sold shares 2 times. They sold a total of 2,153 shares worth more than $8,138.34. The most recent insider tranaction occured on October, 9th when Director Paul Schimmel bought 317,999 shares worth more than $298,919.06. Insiders at aTyr Pharma own 3.7% of the company.
Learn More about insider trades at aTyr Pharma. Information on this page was last updated on 10/9/2025.
